Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Engel

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
Neurology|January 1, 1975
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic featuresG Karpati, S Carpenter, A G Engel, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Recently recognized congenital myasthenic syndromes: (a) end-plate acetylcholine (ACh) esterase deficiency (b) putative abnormality of the ACh induced ion channel (c) putative defect of ACh resynthesis or mobilization - clinical features, ultrastructure and cytochemistryA G Engel, E H Lambert, D M Mulder, et al.
Cancer|October 1, 1995
Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinomaF J Esteva-Lorenzo, J E Janik, R G Fenton, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Myasthenic syndromes attributed to mutations affecting the epsilon subunit of the acetylcholine receptorA G Engel, D O Hutchinson, S Nakano, et al.
Annals of Neurology|June 1, 1982
A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channelA G Engel, E H Lambert, D M Mulder, et al.
Neurology|July 22, 2009
Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patientsM Milone, X M Shen, D Selcen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1997
Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunitM Milone, H L Wang, K Ohno, et al.
Annals of Internal Medicine|July 15, 1990
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiologyR W Martin, J Duffy, A G Engel, et al.
Transactions of the American Neurological Association|January 1, 1979
Investigations of 3 cases of a newly recognized familial, congenital myasthenic syndromeA G Engel, E H Lambert, D M Mulder, et al.
Neuromuscular Disorders : NMD|July 16, 2002
Congenital myasthenic syndrome associated with episodic apnea and sudden infant deathR F Byring, H Pihko, A Tsujino, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Neurology|January 1, 1975
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic featuresG Karpati, S Carpenter, A G Engel, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Recently recognized congenital myasthenic syndromes: (a) end-plate acetylcholine (ACh) esterase deficiency (b) putative abnormality of the ACh induced ion channel (c) putative defect of ACh resynthesis or mobilization - clinical features, ultrastructure and cytochemistryA G Engel, E H Lambert, D M Mulder, et al.
Cancer|October 1, 1995
Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinomaF J Esteva-Lorenzo, J E Janik, R G Fenton, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Myasthenic syndromes attributed to mutations affecting the epsilon subunit of the acetylcholine receptorA G Engel, D O Hutchinson, S Nakano, et al.
Annals of Neurology|June 1, 1982
A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channelA G Engel, E H Lambert, D M Mulder, et al.
Neurology|July 22, 2009
Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patientsM Milone, X M Shen, D Selcen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1997
Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunitM Milone, H L Wang, K Ohno, et al.
Annals of Internal Medicine|July 15, 1990
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiologyR W Martin, J Duffy, A G Engel, et al.
Transactions of the American Neurological Association|January 1, 1979
Investigations of 3 cases of a newly recognized familial, congenital myasthenic syndromeA G Engel, E H Lambert, D M Mulder, et al.
Neuromuscular Disorders : NMD|July 16, 2002
Congenital myasthenic syndrome associated with episodic apnea and sudden infant deathR F Byring, H Pihko, A Tsujino, et al.
Pageof 25